← Back to patent-cliff list
CAS 2627-86-3
(S)-1-phenylethan-1-amine
Codes：APER-019、LEFA-007、POSA-049
Application context (from source-drug indications)
斑块银屑病阿普米司特白塞病综合征阿普米司特口腔溃疡阿普米司特银屑病阿普米司特银屑病关节炎阿普米司特感染来法莫林社区获得性感染来法莫林细菌性肺炎来法莫林肺炎来法莫林社区获得性肺炎来法莫林囊性纤维化来法莫林念珠菌病泊沙康唑曲霉菌属感染泊沙康唑真菌感染泊沙康唑口腔念珠菌病泊沙康唑球孢菌病泊沙康唑组织胞浆菌病泊沙康唑
Source drugs (routes using this intermediate)
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3-ethoxy-4-methoxybenzaldehyde→3-ethoxy-4-methoxybenzonitrile→(S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine→(E)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethenamine→1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanone→(S)-1-phenylethan-1-amine→1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)-N-((S)-1-phenylethyl)ethanamine hydrochloride→(R)-2-methylpropane-2-sulfinamide→(E)-N-(3-ethoxy-4-methoxybenzylidene)-2-methylpropane-2-sulfinamide→N-((S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-2-methylpropane-2-sulfinamide
(3aR,4R,5R,7S,8S,9R,9aS,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-(((1R,2R,4R)-4-((tert-butoxycarbonyl)amino)-2-hydroxycyclohexyl)thio)acetate→cyclohex-3-ene-1-carboxylic acid→(S)-1-phenylethan-1-amine→(S)-1-phenylethan-1-aminium (R)-cyclohex-3-ene-1-carboxylate→(R)-cyclohex-3-ene-1-carboxylic acid→tert-butyl (R)-cyclohex-3-en-1-ylcarbamate→tert-butyl ((1R,3R,6S)-7-oxabicyclo[4.1.0]heptan-3-yl)carbamate→S-((1R,2R,4R)-4-((tert-butoxycarbonyl)amino)-2-hydroxycyclohexyl) benzothioate→tert-butyl ((1R,3R,4R)-3-hydroxy-4-mercaptocyclohexyl)carbamate→(3aR,4R,5R,7S,8S,9R,9aS,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-(tosyloxy)acetate
(S,E)-N'-(2-(benzyloxy)propylidene)formohydrazide→((3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate→phenyl carbonochloridate→N'-((2S,3S)-2-(benzyloxy)pentan-3-yl)formohydrazide→4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2-((2S,3S)-2-(benzyloxy)pentan-3-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one→2-((2S,3S)-2-(benzyloxy)pentan-3-yl)-4-(4-bromophenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one→phenyl (4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)carbamate→2-((2S,3S)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one→methyl 2-hydroxypropanoate→(chloromethyl)benzene→methyl 2-(benzyloxy)propanoate→(S)-1-phenylethan-1-amine→(S)-1-phenylethan-1-amine (S)-2-(benzyloxy)propanoate→methyl (S)-2-(benzyloxy)propanoate→(S)-2-(benzyloxy)propanal→formohydrazide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.